Midgard Science

Labs / CDMO: development & manufacturing

Biome Bank

Adelaide, Australia · biomebank.com

GMP

BiomeBank is a clinical-stage biotechnology company that develops microbiome therapeutics and operates an office and research facility in Adelaide, South Australia. It focuses on restoring gut microbial ecology through donor-derived and cultured microbial products for use in treating disease.

Services can be ordered directly on their website, often with listed prices. Their ordering page

What they offer

  • Donor-derived microbiome therapy

    Develops and supplies a regulated donor-derived microbiome therapy for licensed medical practitioners in Australia.

  • Cultured microbiome therapeutics development

    Designs next-generation co-cultured microbial therapies using its CONSORTIOME platform.

  • Microbiome drug development

    Uses clinical and microbiome data to identify organisms and mechanisms of action for therapy development.

  • Clinical translation of microbiome therapies

    Advances microbiome candidates through discovery, clinical trials, and registration.

What they work on

Modalities
Cell therapy
Species and models
human gut microbiome
Assays and studies
clinical trials, discovery trials, human trials
Instruments and platforms
bioreactor
Therapeutic areas
ulcerative colitis, recurrent Clostridioides difficile infection, inflammatory bowel disease, immunity, metabolism, neurology, oncology, Crohn’s disease
Sites
Adelaide, Australia
Quality
cGMP (manufacturing facility) · Australian regulators approval (BIOMICTRA donor-derived microbiome drug product)
Serves
Australia, global markets
Founded
2018

Similar labs. AGC Biologics, Bambusa Therapeutics, EirGenix, enGenes

Found in a contract services directory. Listing built from biomebank.com. Work here? Claim this listing.